Compounds > tofacitinib

tofacitinib and Granulomatosis-with-Polyangiitis

tofacitinib has been researched along with Granulomatosis-with-Polyangiitis* in 2 studies

Other Studies

2 other study(ies) available for tofacitinib and Granulomatosis-with-Polyangiitis

ArticleYear
Response to Treatment With Tofacitinib in 11 Patients With Refractory Granulomatosis With Polyangiitis.
    The Journal of rheumatology, 2023, Volume: 50, Issue:8

    Topics: Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Piperidines; Rituximab

2023
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:12

    Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Blood Sedimentation; C-Reactive Protein; Churg-Strauss Syndrome; Female; Granulomatosis with Polyangiitis; Humans; Janus Kinase Inhibitors; Male; Microscopic Polyangiitis; Middle Aged; Pilot Projects; Piperidines; Pyrimidines; Treatment Outcome; Young Adult

2021